Andrew Oxtoby - Net Worth and Insider Trading

Andrew Oxtoby Net Worth

The estimated net worth of Andrew Oxtoby is at least $862,767 dollars as of 2024-05-14. Andrew Oxtoby is the Chief Commercial Officer of Aimmune Therapeutics Inc and owns about 25,015 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $862,767. Details can be seen in Andrew Oxtoby's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Oxtoby has not made any transactions after 2020-03-13 and currently still holds the listed stock(s).

Transaction Summary of Andrew Oxtoby

To

Andrew Oxtoby Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Oxtoby owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Chinook Therapeutics Inc (KDNY) .

Click here to see the complete history of Andrew Oxtoby’s form 4 insider trades.

Insider Ownership Summary of Andrew Oxtoby

Ticker Comapny Transaction Date Type of Owner
AIMT Aimmune Therapeutics Inc 2020-10-10 Chief Commercial Officer
KDNY Chinook Therapeutics Inc 2023-02-15 Chief Commercial Officer

Andrew Oxtoby Latest Holdings Summary

Andrew Oxtoby currently owns a total of 1 stock. Andrew Oxtoby owns 25,015 shares of Aimmune Therapeutics Inc (AIMT) as of March 13, 2020, with a value of $862,767.

Latest Holdings of Andrew Oxtoby

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AIMT Aimmune Therapeutics Inc 2020-03-13 25,015 34.49 862,767

Holding Weightings of Andrew Oxtoby


Andrew Oxtoby Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Oxtoby has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 3,000 shares on March 13, 2020, which cost Andrew Oxtoby around $44,280.

Insider Trading History of Andrew Oxtoby

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Oxtoby Trading Performance

GuruFocus tracks the stock performance after each of Andrew Oxtoby's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Oxtoby is 19.36%. GuruFocus also compares Andrew Oxtoby's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Oxtoby within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew Oxtoby's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew Oxtoby

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.08
Relative Return to S&P 500(%) 5.21

Andrew Oxtoby Ownership Network

Ownership Network List of Andrew Oxtoby

No Data

Ownership Network Relation of Andrew Oxtoby


Andrew Oxtoby Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Andrew Oxtoby is the Chief Commercial Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aimmune Therapeutics Inc Insider Transactions

No Available Data

Andrew Oxtoby Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Oxtoby. You might contact Andrew Oxtoby via mailing address: 8000 Marina Boulevard, Suite 300, Brisbane Ca 94005.

Discussions on Andrew Oxtoby

No discussions yet.